Palatin Technologies
PTN
#10932
Rank
NZ$16.69 M
Marketcap
NZ$9.37
Share price
-4.10%
Change (1 day)
-58.36%
Change (1 year)

Palatin Technologies (PTN) - Net assets

Net assets on the balance sheet as of June 2026 : NZ$12.16 Million

According to Palatin Technologies's latest financial reports the company has NZ$12.16 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Palatin Technologies - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-06-30$-NZ$7.85 Million4189.24%
2024-06-30$-NZ$0.19 Million-94.34%
2023-06-30$-NZ$3.23 Million-112.38%
2022-06-30$NZ$26.06 M-63.26%
2021-06-30$NZ$70.96 M-42.9%
2020-06-30$NZ$0.12 B-16.9%
2019-06-30$NZ$0.14 B275.6%
2018-06-30$NZ$39.81 M-664.43%
2017-06-30$-NZ$7.06 Million-71.37%
2016-06-30$-NZ$24.65 Million-237.04%
2015-06-30$NZ$17.98 M60.97%
2014-06-30$NZ$11.17 M-62.38%
2013-06-30$NZ$29.69 M1201.66%
2012-06-30$NZ$2.28 M-89.61%
2011-06-30$NZ$21.96 M63.02%
2010-06-30$NZ$13.47 M160.65%
2009-06-30$NZ$5.16 M-39.99%
2008-06-30$NZ$8.61 M-64.27%
2007-06-30$NZ$24.1 M-20.22%
2006-06-30$NZ$30.21 M124.03%
2005-06-30$NZ$13.48 M-55.5%
2004-06-30$NZ$30.31 M-5.41%
2003-06-30$NZ$32.04 M79.28%
2002-06-30$NZ$17.87 M-39.02%
2001-06-30$NZ$29.3 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$148.38 B 1,219,214.85%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$91.67 B 753,213.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$6.72 B 55,139.99%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ$67.83 M 457.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$1.76 B 14,369.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$1.08 B 8,831.66%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
NZ$6.14 M-49.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.27 B 2,128.58%๐Ÿ‡บ๐Ÿ‡ธ USA